B-cell dysregulation in Crohn's disease is partially restored with infliximab therapy

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Timmermans, Wilhelmina M C ^a   Van Laar, Jan A M ^a   Van Der Houwen, Tim B ^a   Kamphuis, Lieke S J ^a   Bartol, Sophinus J W ^a   Lam, King H ^a   Ouwendijk, Rob J ^b   Sparrow, Miles P ^c   Gibson, Peter R ^c   Van Hagen, P Martin ^a   Van Zelm, Menno C ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b IKAZIA HOSPITAL   (Netherlands)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD24 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLIXIMAB; SYNDECAN 1;

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; INTESTINE BIOPSY; LYMPHOCYTIC INFILTRATION; MALE; MEMORY CELL; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT MONITORING; PHENOTYPE; SOMATIC HYPERMUTATION; YOUNG ADULT; IMMUNOLOGY;

ADULT; B-LYMPHOCYTES; CROHN DISEASE; FEMALE; HUMANS; INFLIXIMAB; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84982740516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0160103     Document Type: Article

References (51)

1. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet. 2012; 380(9853):1590-605. Epub 2012/08/24. doi: S0140-6736(12)60026-9 [pii] doi: 10.1016/S0140-6736(12)60026-9 PMID: 22914295.
2. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007; 369(9573):1627-40. PMID: 17499605.
3. Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmunity reviews. 2014; 13(1):3-10. doi: 10.1016/j.autrev.2013.06.004 PMID: 23774107.
4. Hisamatsu T, Kanai T, Mikami Y, Yoneno K, Matsuoka K, Hibi T. Immune aspects of the pathogenesis of inflammatory bowel disease. Pharmacol Ther. 2013; 137(3):283-97. Epub 2012/10/30. doi: S0163-7258(12)00233-1 [pii] doi: 10.1016/j.pharmthera.2012.10.008 PMID: 23103332.
5. Heresbach D, Alexandre JL, Branger B, Bretagne JF, Cruchant E, Dabadie A, et al. Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease. Gut. 2005; 54(2):215-22. doi: 10.1136/gut.2004.041715 PMID: 15647184; PubMed Central PMCID: PMC1774855.
6. Lennard-Jones JE, Lockhart-Mummery HE, Morson BC. Clinical and pathological differentiation of Crohn's disease and proctocolitis. Gastroenterology. 1968; 54(6):1162-70. Epub 1968/06/01. PMID: 5656336.
7. Geboes K, van den Oord J, De Wolf-Peeters C, Desmet V, Rutgeerts P, Janssens J, et al. The cellular composition of granulomas in mesenteric lymph nodes from patients with Crohn's disease. Virchows Archiv A, Pathological anatomy and histopathology. 1986; 409(5):679-92. PMID: 3092463.
8. Kamphuis LS, van Zelm MC, Lam KH, Rimmelzwaan GF, Baarsma GS, Dik WA, et al. Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis? American journal of respiratory and critical care medicine. 2013; 187(4):406-16. doi: 10.1164/rccm.201206-1024OC PMID: 23239158.
9. Saussine A, Tazi A, Feuillet S, Rybojad M, Juillard C, Bergeron A, et al. Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PloS one. 2012; 7(8):e43588. doi: 10.1371/journal.pone.0043588 PMID: 22927996; PubMed Central PMCID: PMC3425471.
10. Lee NS, Barber L, Akula SM, Sigounas G, Kataria YP, Arce S. Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis. Clin Vaccine Immunol. 2011; 18(8):1306-16. Epub 2011/06/10. doi: CVI.05118-11 [pii] doi: 10.1128/CVI.05118-11 PMID: 21653741; PubMed Central PMCID: PMC3147362.
11. Sieber G, Herrmann F, Zeitz M, Teichmann H, Ruhl H. Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease. Gut. 1984; 25(11):1255-61. PMID: 6238880.
12. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998; 42(6):788-91. Epub 1998/08/06. PMID: 9691915; PubMed Central PMCID: PMC1727156.
13. van Schaik FD, Oldenburg B, Hart AR, Siersema PD, Lindgren S, Grip O, et al. Serological markers predict inflammatory bowel disease years before the diagnosis. Gut. 2013; 62(5):683-8. Epub 2012/07/31. doi: gutjnl-2012-302717 [pii] doi: 10.1136/gutjnl-2012-302717 PMID: 22842615.
14. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000; 1(6):475-82. Epub 2001/03/23. doi: 10.1038/82717 PMID: 11101868.
15. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006; 176(2):705-10. Epub 2006/01/06. doi: 176/2/705 [pii]. PMID: 16393950.
16. Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. International immunology. 2000; 12(5):597-605. PMID: 10784605.
17. Olson TS, Bamias G, Naganuma M, Rivera-Nieves J, Burcin TL, Ross W, et al. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Invest. 2004; 114(3):389-98. Epub 2004/08/03. doi: 10.1172/JCI20855 PMID: 15286805; PubMed Central PMCID: PMC484978.
18. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008; 112(5):1570-80. doi: 10.1182/blood-2008-02-078071 PMID: 18725575; PubMed Central PMCID: PMC2518873.
19. Di Sabatino A, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Corazza GR, et al. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. The American journal of gastroenterology. 2005; 100(8):1788-95. doi: 10.1111/j.1572-0241.2005.41939.x PMID: 16086716.
20. Kruetzmann S, Rosado MM, Weber H, Germing U, Tournilhac O, Peter HH, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med. 2003; 197(7):939-45. Epub 2003/04/12. doi: 10.1084/jem.20022020 [pii]. PMID: 12682112; PubMed Central PMCID: PMC2193885.
21. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 2004; 104(12):3647-54. PMID: 15191950.
22. Berkowska MA, Driessen GJ, Bikos V, Grosserichter-Wagener C, Stamatopoulos K, Cerutti A, et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood. 2011. PMID: 21690558.
23. Kalina T, Flores-Montero J, van der Velden VH, Martin-Ayuso M, Bottcher S, Ritgen M, et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. 2012; 26(9):1986-2010. Epub 2012/09/06. doi: leu2012122 [pii] doi: 10.1038/leu.2012.122 PMID: 22948490; PubMed Central PMCID: PMC3437409.
24. Berkowska MA, Heeringa JJ, Hajdarbegovic E, van der Burg M, Thio HB, van Hagen PM, et al. Human IgE(+) B cells are derived from T cell-dependent and T cell-independent pathways. J Allergy Clin Immunol. 2014; 134(3):688-97 e6. Epub 2014/05/20. doi: 10.1016/j.jaci.2014.03.036 PMID: 24835500.
25. van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007; 204(3):645-55. Epub 2007/02/22. doi: jem.20060964 [pii] doi: 10.1084/jem.20060964 PMID: 17312005; PubMed Central PMCID: PMC2137914.
26. Brandtzaeg P, Farstad IN, Johansen FE, Morton HC, Norderhaug IN, Yamanaka T. The B-cell system of human mucosae and exocrine glands. Immunol Rev. 1999; 171:45-87. PMID: 10582165.
27. Crabbe PA, Carbonara AO, Heremans JF. The Normal Human Intestinal Mucosa as a Major Source of Plasma Cells Containing Gamma-a-Immunoglobulin. Laboratory investigation; a journal of technical methods and pathology. 1965; 14:235-48. PMID: 14289438.
28. Yaari G, Uduman M, Kleinstein SH. Quantifying selection in high-throughput Immunoglobulin sequencing data sets. Nucleic Acids Res. 2012; 40(17):e134. Epub 2012/05/30. doi: gks457 [pii] doi: 10.1093/nar/gks457 PMID: 22641856; PubMed Central PMCID: PMC3458526.
29. Uduman M, Yaari G, Hershberg U, Stern JA, Shlomchik MJ, Kleinstein SH. Detecting selection in immunoglobulin sequences. Nucleic Acids Res. 2011; 39(Web Server issue):W499-504. Epub 2011/06/15. doi: gkr413 [pii] doi: 10.1093/nar/gkr413 PMID: 21665923; PubMed Central PMCID: PMC3125793.
30. Berkowska MA, Grosserichter-Wagener C, Adriaansen HJ, de Ridder D, Mirani-Oostdijk KP, Agteresch HJ, et al. Persistent polyclonal B-cell lymphocytosis: extensively proliferated CD27+IgM+IgD+ memory B cells with a distinctive immunophenotype. Leukemia. 2014; 28(7):1560-4. Epub 2014/02/20. doi: 10.1038/leu.2014.77 PMID: 24549258.
31. van Zelm MC, Bartol SJ, Driessen GJ, Mascart F, Reisli I, Franco JL, et al. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. J Allergy Clin Immunol. 2014; 134(1):135-44. Epub 2014/01/15. doi: 10.1016/j.jaci.2013.11.015 PMID: 24418477.
32. Jackson KJ, Wang Y, Collins AM. Human immunoglobulin classes and subclasses show variability in VDJ gene mutation levels. Immunol Cell Biol. 2014; 92(8):729-33. Epub 2014/06/11. doi: icb201444 [pii] doi: 10.1038/icb.2014.44 PMID: 24913324.
33. van Zelm MC. B cells take their time: sequential IgG class switching over the course of an immune response? Immunol Cell Biol. 2014; 92(8):645-6. Epub 2014/06/18. doi: 10.1038/icb.2014.48 PMID: 24935459.
34. Di Sabatino A, Rosado MM, Cazzola P, Biancheri P, Tinozzi FP, Laera MR, et al. Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab. Inflammatory bowel diseases. 2008; 14(5):591-6. doi: 10.1002/ibd.20374 PMID: 18240280.
35. Janssen CE, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R, et al. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease. J Allergy Clin Immunol. 2012; 129(4):1076-84. Epub 2012/04/03. doi: S0091-6749(12)00265-5 [pii] doi: 10.1016/j.jaci.2012.02.004 PMID: 22464675.
36. Sweiss NJ, Lower EE, Mirsaeidi M, Dudek S, Garcia JG, Perkins D, et al. Rituximab in the treatment of refractory pulmonary sarcoidosis. The European respiratory journal. 2014; 43(5):1525-8. doi: 10.1183/09031936.00224513 PMID: 24488568; PubMed Central PMCID: PMC4167390.
37. Chen H, Liao D, Holl TM, Snowden P, Ueda Y, Kelsoe G. Genetic regulation of pristane-induced oil granuloma responses. International journal of experimental pathology. 2010; 91(5):472-83. doi: 10.1111/j.1365-2613.2010.00732.x PMID: 20804539; PubMed Central PMCID: PMC3003845.
38. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. The Quarterly journal of medicine. 1993; 86(1):31-42. PMID: 8438047.
39. Blombery P, Prince HM, Levinson M, Pianko S, Maxwell E, Bhathal P. Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma. J Clin Oncol. 2011; 29(5):e110-2. Epub 2010/11/26. doi: JCO.2010.31.8899 [pii] doi: 10.1200/JCO.2010.31.8899 PMID: 21098319.
40. Papadakis KA, Rosenbloom B, Targan SR. Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease. Gastroenterology. 2003; 124(2):583. doi: 10.1053/gast.2003.50081 PMID: 12557172.
41. Rogosnitzky M, Danks R, Holt D. Intravenous immunoglobulin for the treatment of Crohn's disease. Autoimmunity reviews. 2012; 12(2):275-80. Epub 2012/05/15. doi: S1568-9972(12)00096-1 [pii] doi: 10.1016/j.autrev.2012.04.006 PMID: 22579561.
42. Nishida A, Lau CW, Mizoguchi E, Mizoguchi A. Regulatory B cells in mouse models of intestinal inflammation. Methods Mol Biol. 2014; 1190:227-41. Epub 2014/07/13. doi: 10.1007/978-1-4939-1161-5-16 PMID: 25015284.
43. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood. 2005; 105(11):4390-8. Epub 2005/02/11. doi: 2004-11-4284 [pii] doi: 10.1182/blood-2004-11-4284 PMID: 15701725; PubMed Central PMCID: PMC1895038.
44. Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, Srdanovic I, et al. Complement receptor 2/CD21-human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010; 115(24):5026-36. Epub 2010/03/17. doi: blood-2009-09-243071 [pii] doi: 10.1182/blood-2009-09-243071 PMID: 20231422.
45. Moir S, Malaspina A, Ogwaro KM, Donoghue ET, Hallahan CW, Ehler LA, et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci U S A. 2001; 98(18):10362-7. Epub 2001/08/16. doi: 10.1073/pnas.181347898 [pii]. PMID: 11504927; PubMed Central PMCID: PMC56966.
46. Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, Peter HH, et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol. 2004; 113(2):161-71. Epub 2004/09/29. doi: 10.1016/j.clim.2004.05.010 S1521-6616(04)00181-0 [pii]. PMID: 15451473.
47. Verstegen RH, Driessen GJ, Bartol SJ, van Noesel CJ, Boon L, van der Burg M, et al. Defective B-cell memory in patients with Down syndrome. J Allergy Clin Immunol. 2014. Epub 2014/08/28. doi: S0091-6749(14)00970-1 [pii] doi: 10.1016/j.jaci.2014.07.015 PMID: 25159464.
48. Rakhmanov M, Gutenberger S, Keller B, Schlesier M, Peter HH, Warnatz K. CD21low B cells in common variable immunodeficiency do not show defects in receptor editing, but resemble tissue-like memory B cells. Blood. 2010; 116(18):3682-3. Epub 2010/11/06. doi: 116/18/3682 [pii] doi: 10.1182/blood-2010-05-285585 PMID: 21051568.
49. Li Z, Vermeire S, Bullens D, Ferrante M, Van Steen K, Noman M, et al. Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases. Inflammatory bowel diseases. 2015; 21(12):2787-96. doi: 10.1097/MIB.0000000000000554 PMID: 26383913.
50. Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut. 2012; 61(11):1619-35. Epub 2012/07/31. doi: gutjnl-2012-302830 [pii] doi: 10.1136/gutjnl-2012-302830 PMID: 22842618.
51. Berkowska MA, Schickel JN, Grosserichter-Wagener C, de Ridder D, Ng YS, van Dongen JJ, et al. Circulating Human CD27-IgA+ Memory B Cells Recognize Bacteria with Polyreactive Igs. J Immunol. 2015; 195(4):1417-26. doi: 10.4049/jimmunol.1402708 PMID: 26150533.